tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ADCT Stock Latest News

ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy
Company AnnouncementsADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy
4d ago
8K
ADCT
ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook
PremiumCompany Announcements
ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook
8d ago
8K
ADCT
ADC Therapeutics sees FY25 net product revenue $73M
PremiumThe Fly
ADC Therapeutics sees FY25 net product revenue $73M
8d ago
ADCT
ADC Therapeutics sees Q4 net product revenue $22M
PremiumThe Fly
ADC Therapeutics sees Q4 net product revenue $22M
8d ago
ADCT
ADC Therapeutics Reports Promising LOTIS-7 Trial Results
PremiumCompany Announcements
ADC Therapeutics Reports Promising LOTIS-7 Trial Results
1M ago
8K
ADCT
Promising LOTIS-7 Trial Results Reinforce Buy Rating for ADC Therapeutics
PremiumRatingsPromising LOTIS-7 Trial Results Reinforce Buy Rating for ADC Therapeutics
1M ago
ADCT
ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma
Premium
The Fly
ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma
1M ago
ADCT
ADC Therapeutics: Strong Financials and Upcoming Trial Catalysts Support Buy Rating
Premium
Ratings
ADC Therapeutics: Strong Financials and Upcoming Trial Catalysts Support Buy Rating
2M ago
ADCT
ADC Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
ADC Therapeutics Reports Q3 2025 Financial Results
2M ago
ADCT
ADC Therapeutics Q3 2025 Earnings Call Highlights
PremiumCompany Announcements
ADC Therapeutics Q3 2025 Earnings Call Highlights
2M ago
ADCT
ADC Therapeutics files to sell 14.7M common shares for holders
PremiumThe Fly
ADC Therapeutics files to sell 14.7M common shares for holders
2M ago
ADCT
ADC Therapeutics reports Q3 adjsuted EPS (19c), consensus (36c)
PremiumThe Fly
ADC Therapeutics reports Q3 adjsuted EPS (19c), consensus (36c)
2M ago
ADCT
Is ADCT a Buy, Before Earnings?
PremiumPre-EarningsIs ADCT a Buy, Before Earnings?
2M ago
ADCT
ADC Therapeutics’ LOTIS-7 Study: A Promising Update for Investors
Premium
Company Announcements
ADC Therapeutics’ LOTIS-7 Study: A Promising Update for Investors
3M ago
ADCT
ADC Therapeutics’ LOTIS-10 Study: A Step Forward in Lymphoma Treatment
Premium
Company Announcements
ADC Therapeutics’ LOTIS-10 Study: A Step Forward in Lymphoma Treatment
3M ago
ADCT
ADC Therapeutics price target lowered to $7 from $8 at H.C. Wainwright
PremiumThe Fly
ADC Therapeutics price target lowered to $7 from $8 at H.C. Wainwright
3M ago
ADCT
ADC Therapeutics Announces $60M Private Placement
PremiumCompany Announcements
ADC Therapeutics Announces $60M Private Placement
3M ago
8K
ADCT
ADC Therapeutics sees Q3 sales of zynlonta about $15.8M
PremiumThe Fly
ADC Therapeutics sees Q3 sales of zynlonta about $15.8M
3M ago
ADCT
ADC Therapeutics announces $60M private placement
PremiumThe Fly
ADC Therapeutics announces $60M private placement
3M ago
ADCT
Positive Buy Rating for ADC Therapeutics Amid Promising Clinical Trials and Strong Valuation
PremiumRatingsPositive Buy Rating for ADC Therapeutics Amid Promising Clinical Trials and Strong Valuation
4M ago
ADCT
ADC Therapeutics Updates Strategic Focus on ZYNLONTA
Premium
Company Announcements
ADC Therapeutics Updates Strategic Focus on ZYNLONTA
4M ago
8K
ADCT
ADC Therapeutics Earnings Call: Growth Amid Challenges
Premium
Company Announcements
ADC Therapeutics Earnings Call: Growth Amid Challenges
5M ago
ADCT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >